Similar articles

• ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.

  Lewis SJ, Hashmi-Hill MP, Owen JR, Sandock K, Robertson TP, Bates JN. Lewis SJ, et al. Vascul Pharmacol. 2006 Jun;44(6):491-507. doi: 10.1016/j.vph.2006.03.003. Epub 2006 May 18. Vascul Pharmacol. 2006. PMID: 16713366
• Antioxidant activity and inhibitory effects of hydralazine on inducible NOS/COX-2 gene and protein expression in rat peritoneal macrophages.

  Leiro JM, Alvarez E, Arranz JA, Cano E, Orallo F. Leiro JM, et al. Int Immunopharmacol. 2004 Feb;4(2):163-77. doi: 10.1016/j.intimp.2003.10.004. Int Immunopharmacol. 2004. PMID: 14996408
• The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine.

  Daiber A, Mülsch A, Hink U, Mollnau H, Warnholtz A, Oelze M, Münzel T. Daiber A, et al. Am J Cardiol. 2005 Oct 10;96(7B):25i-36i. doi: 10.1016/j.amjcard.2005.07.030. Epub 2005 Aug 8. Am J Cardiol. 2005. PMID: 16226933 Review.
• The effects of hydralazine on lipolysis in subcutaneous adipose tissue in humans.

  Boon N, Goossens GH, Blaak EE, Saris WH. Boon N, et al. Metabolism. 2007 Dec;56(12):1742-8. doi: 10.1016/j.metabol.2007.08.003. Metabolism. 2007. PMID: 17998030
• Effects of hydralazine on the pulmonary vasculature and respiratory control in humans.

  Liu C, Balanos GM, Fatemian M, Smith TG, Dorrington KL, Robbins PA. Liu C, et al. Exp Physiol. 2008 Jan;93(1):104-14. doi: 10.1113/expphysiol.2007.039750. Epub 2007 Oct 2. Exp Physiol. 2008. PMID: 17911356